5OWQ
Human STK10 bound to dovitinib
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | DIAMOND BEAMLINE I04-1 |
| Synchrotron site | Diamond |
| Beamline | I04-1 |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2012-02-18 |
| Detector | DECTRIS PILATUS 2M |
| Wavelength(s) | 0.9173 |
| Spacegroup name | P 1 21 1 |
| Unit cell lengths | 57.570, 50.400, 114.570 |
| Unit cell angles | 90.00, 96.60, 90.00 |
Refinement procedure
| Resolution | 57.190 - 2.700 |
| R-factor | 0.26535 |
| Rwork | 0.263 |
| R-free | 0.30495 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | STK10 |
| RMSD bond length | 0.014 |
| RMSD bond angle | 1.693 |
| Data scaling software | Aimless |
| Phasing software | PHASER |
| Refinement software | REFMAC (5.8.0158) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 57.190 | 2.860 |
| High resolution limit [Å] | 2.700 | 2.700 |
| Rmerge | 0.140 | 0.610 |
| Number of reflections | 16619 | 2672 |
| <I/σ(I)> | 4.7 | 1.3 |
| Completeness [%] | 91.4 | 91.8 |
| Redundancy | 2.8 | 2.7 |
| CC(1/2) | 0.984 | 0.692 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 277 | 0.1M sodium formate, 15%(w/v) PEG 3350 |






